Outcomes of a novel thin-strut bioresorbable-polymer sirolimus-eluting stent in patients with chronic total occlusions: A multicenter registry

A study to evaluate the mid-term outcomes of a novel thin-strut bioresorbable-polymer sirolimus-eluting stent in chronic total occlusion percutaneous coronary intervention (Int J Cardiol 2018 Jan 31)

15 Febbraio Feb 2018 8 months ago
  • Grancini L, Trabattoni D, Bartorelli AL

The Authors of this paper aimed to evaluate the mid-term outcomes of a novel thin-strut bioresorbable-polymer sirolimus-eluting stent (BP-SES) in chronic total occlusion (CTO) percutaneous coronary intervention (PCI), as compared with durable-polymer everolimus-eluting stents (EES).

Reference

  • Azzalini L, Demir OM, Gasparini GL, Grancini L, La Manna A, Ojeda S, Benincasa S, Bellini B, Poletti E, Maccagni D, Soldi M, Iannetta L, Trabattoni D, Gravina G, Hidalgo F, Giannini F, Pan M, Tamburino C, Bartorelli AL, Reimers B, Godino C, Carlino M, Colombo A. Outcomes of a novel thin-strut bioresorbable-polymer sirolimus-eluting stent in patients with chronic total occlusions: A multicenter registry. Int J Cardiol 2018 Jan 31. pii: S0167-5273(17)37840-3. doi: 10.1016/j.ijcard.2018.01.115. [Epub ahead of print] Go to PubMed